1984
DOI: 10.1111/j.1600-0536.1984.tb00939.x
|View full text |Cite
|
Sign up to set email alerts
|

Allergic contact dermatitis to zinc pyrithione

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1985
1985
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…In only one of our patients was the Zinc Omadine reaction interpreted with certainty as being of present relevance. It is noteworthy that a concomitant nickel allergy was found in 2 patients, which was also found in 3 of the published patients (1,3). We are unable to explain this coincidence, cross-sensitivity being unlikely.…”
Section: + + +mentioning
confidence: 68%
See 1 more Smart Citation
“…In only one of our patients was the Zinc Omadine reaction interpreted with certainty as being of present relevance. It is noteworthy that a concomitant nickel allergy was found in 2 patients, which was also found in 3 of the published patients (1,3). We are unable to explain this coincidence, cross-sensitivity being unlikely.…”
Section: + + +mentioning
confidence: 68%
“…It is known under the proprietary names Zinc Omadine®, Vancide ZP® and Zincon® (1). Despite widespread use, only 5 case reports on contact allergy (1)(2)(3)(4)…”
mentioning
confidence: 99%
“…Pyrithione is a more frequent cosmetic sensitizer. Zinc pyrithione, CAS 13463‐41‐7, is largely used in anti‐dandruff preparations (9–14). Since the hapten is the pyrithione moiety, either zinc or sodium pyrithione can be used for patch testing, pet.…”
Section: Discussionmentioning
confidence: 99%
“…In animal sensitization studies, which involve initial contact and subsequent challenge to simulate the elicitation and induction phases of response [ 154 ], ZnPT was deemed not to have any sensitization potential [ 12 ]. Unsurprisingly, for a drug so widely used since it was first approved there have been isolated case reports of human sensitivity to ZnPT [ 155 , 156 , 157 , 158 , 159 ]. The occurrence of sensitivity does however remain very low, with a positive patch test rate ranging from 0.002% (3 individuals out of 1652) [ 155 ] to 1.2% (2 individuals out of 171) [ 156 ].…”
Section: Toxicity Assessmentmentioning
confidence: 99%